Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy
Clinical trial NCT06070051 · COMPLETED
Trial details
- NCT number
- NCT06070051
- Sponsor
- Virion Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-26
- Primary completion
- 2026-03-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.